Join us on September 11th for a deep-dive into the evolving reimbursement landscape during our one day masterclass which brings together a mix of industry stakeholders and expert speakers including a speaker from the German based Ecker & Ecker who will bring some practical insights into the EU HTA process.
Event Details:
-
- Date: Thursday, 11th September
- Time: 9.30am start, close at 4pm
- Venue: IMI campus, Sandyford, Dublin
- Audience: Max of 25 seats, this masterclass will be best suited to those working in Market Access roles or those who need a deeper understanding of the reimbursement process
Meet the speakers:
(alphabetical order)
Claire Barry, Head of Consulting – Salutem Insights
Claire is an accomplished pharmaceutical professional with over 20 years of experience focused on health economics and patient access. With a PhD in Neurophysiology from Trinity College Dublin and a Postgraduate Certificate in Health Economics from the University of York, she combines scientific depth with strategic leadership. Formerly Head of Patient Access at Bayer Pharmaceuticals and a member of the IPHA Market Access Advisory Forum, Claire has secured reimbursement for a broad range of therapies by navigating the Irish reimbursement process, including HTAs and horizon scans. Now as Head of Consulting at Salutem Insights, she applies this expertise to help clients address complex market access challenges across multiple therapeutic areas.
Bernard Duggan, Chief Pharmacist – Medicines Management Programme (HSE)
Bernard is Chief I Pharmacist in the HSE – Medicines Management Programme. His work involves delivery and oversight of health technology management programmes in the Irish healthcare service, that is, measures put in place to enhance the safe, effective and cost-effective use of medicines on a national level.
Bernard’s role includes leading the best-value biological medicine initiative, which has focused on increasing the prescribing and utilisation of biosimilar medicines, including TNF-α inhibitors (adalimumab and etanercept) and teriparatide. In addition, he has led the development and implementation of managed access processes to facilitate reimbursement of innovative medicines.
Bernard obtained his undergraduate pharmacy degree from Trinity College Dublin, and registered as a pharmacist in 2005. In addition, he has been awarded diplomas in project management and health economics. He has previously worked in both community pharmacy and regulatory roles.
Marian Hernon, Health Economics Manager – Amgen
* bio to follow *
Sandra Redmond, Managing Director – Salutem Insights
Sandra is the Managing Director of Salutem Insights and an economist with deep expertise in health economics and market access strategy. With over two decades in the pharmaceutical industry, she has advised on complex reimbursement processes, health technology assessments (HTAs), and policy shaping across a wide range of therapeutic areas. Sandra combines analytical rigour with commercial insight to help clients navigate market access challenges, drawing on her extensive experience to develop evidence-based solutions that drive patient access and sustainable outcomes.
Stephanie Stengel, Senior Manager, Market Access – Ecker & Ecker GmbH
* bio to follow *
Further speakers will be confirmed shortly.
——-
Proudly supported by:
Salutem Insights are a leading health economics and market access consultancy based in Ireland. The firm supports pharmaceutical and biotech companies in navigating the complex Irish reimbursement landscape, drawing on deep expertise in health technology assessments (HTAs), rapid reviews, pricing strategy, and stakeholder engagement. By combining rigorous economic analysis with practical market insight, Salutem Insights helps clients secure patient access for new and existing therapies across a range of therapeutic areas.
Please note that by registering for this event you agree to share your name and company details with the organisers and the event sponsor.
